41409711000001100: Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)
\UK product\Virtual medicinal product\Product containing precisely esomeprazole 40 milligram/1 each conventional release oral tablet\Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)
\UK product\Virtual therapeutic moiety\Esomeprazole\Product containing only esomeprazole in oral dose form (medicinal product form)\Product containing precisely esomeprazole 40 milligram/1 each conventional release oral tablet\Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)
\UK product\Virtual therapeutic moiety\Esomeprazole\Product containing precisely esomeprazole 40 milligram/1 each conventional release oral tablet\Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing hydrogen/potassium adenosine triphosphatase enzyme system inhibitor (product)\Product containing esomeprazole\Esomeprazole\Product containing only esomeprazole in oral dose form (medicinal product form)\Product containing precisely esomeprazole 40 milligram/1 each conventional release oral tablet\Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing hydrogen/potassium adenosine triphosphatase enzyme system inhibitor (product)\Product containing esomeprazole\Esomeprazole\Product containing precisely esomeprazole 40 milligram/1 each conventional release oral tablet\Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing hydrogen/potassium adenosine triphosphatase enzyme system inhibitor (product)\Product containing esomeprazole\Product containing esomeprazole in oral dose form (medicinal product form)\Product containing only esomeprazole in oral dose form (medicinal product form)\Product containing precisely esomeprazole 40 milligram/1 each conventional release oral tablet\Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzimidazole\Product containing esomeprazole\Esomeprazole\Product containing only esomeprazole in oral dose form (medicinal product form)\Product containing precisely esomeprazole 40 milligram/1 each conventional release oral tablet\Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzimidazole\Product containing esomeprazole\Esomeprazole\Product containing precisely esomeprazole 40 milligram/1 each conventional release oral tablet\Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzimidazole\Product containing esomeprazole\Product containing esomeprazole in oral dose form (medicinal product form)\Product containing only esomeprazole in oral dose form (medicinal product form)\Product containing precisely esomeprazole 40 milligram/1 each conventional release oral tablet\Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing esomeprazole in oral dose form (medicinal product form)\Product containing only esomeprazole in oral dose form (medicinal product form)\Product containing precisely esomeprazole 40 milligram/1 each conventional release oral tablet\Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Feb 2023. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2284631000001117 Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2397421000001115 Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)	Is a	Product containing precisely esomeprazole 40 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)	Has dispensed dose form	Gastro-resistant oral tablet	true	Inferred relationship	Existential restriction modifier
Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)	Has specific active ingredient	Esomeprazole	true	Inferred relationship	Existential restriction modifier
Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd) 28 tablet 4 x 7 tablets	Has AMP	True	Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2284631000001117	Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2397421000001115	Esomeprazole 40mg gastro-resistant tablets (Crescent Pharma Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module